Better Pharma Processes LogoBetter Pharma Processes for Small Molecule Drugs
Better Pharma Processes provides process chemistry consulting and training

Associates

Consortium of Process Experts

Successful process implementation requires collaboration with colleagues in many disciplines. Dr. Harrington and Better Pharma Processes, LLC is associated with a consortium of internationally recognized experts in several key process disciplines.

Tomasso Foderaro, Ph.D. - Analytical Method Development/Validation
Peter J. Harrington, Ph.D. - Process Research/Process Transition to Pilot Plant
Dave Johnston, Ph.D. - Project Management/Process Research
Barry King, Ph.D. - Process Research/Process Transition to Manufacturing
    Plant
Gerald McEwen, Ph.D. - Process Safety/Thermal Hazard Analysis/Calorimetry

 

© 2010 better pharma processes; all rights reserved


Better Pharma Processes, owned by Peter Harrington, PhD, provides consulting and training in the field of pharmaceutical process chemistry. 
Dr. Harrington's newest book, "Pharmaceutical Process Chemistry for Synthesis: Rethinking the Routes to Scale-Up", describes the process chemistry involved in several popular small-molecule drugs, including abilify®, celebrex®, crestor®, cymbalta®, flonase®, levaquin®, topamax®, valtrex®, and zyprexa®.